Zheng Lab · GCCRI

Publications

Publications

96 peer-reviewed papers since 2006, of which 27 as first or senior author. Papers led from my lab are highlighted below.

* denotes co-first or co-senior (corresponding) author.

96
Total papers
27
First / senior author
2006
Publishing since
Highlighted = led from the Zheng lab
2026

EWSR1::FLI1 promotes neocentromere formation in ewing sarcoma cells

Kitagawa R, Metitiri EE, Yu B, Shen C, Bishop AJR, Zheng S, Houghton PJ, Kitagawa K

Cell Rep · 2026 · 45(8):117846

HELZ-BRCA2 complex resolves R-loops to drive transcription-coupled homologous recombination

Li W, Wu B, Gao B, Irvin EM, Ghosh A, Eliaz L … Yu DS, Zheng S, Leung J … Zhao W

Nat Commun · 2026 · 17(1):6969

2025

Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis

Evans RC, Dar NJ, Chen L, Na R, O'Connor JC, Jiang J, Zheng S, Ran Q

Aging Cell · 2025 · 24(11):e70218

Ligand-receptor interactions induce and mediate regulatory functions of BATF3(+) B cells

Yan H, Wang R, Viswanadhapalli S, Cervantes C, He F, Wu S … Ebrahimi D, Zheng S, Curiel TJ … Xu Z

Sci Adv · 2025 · 11(41):eadx9917

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors

Wang J, Sarkar A, Garcia N, Zhang L, Calizo A, Lisok A … Pollard K, Zheng S, Lucas CG … Vaseva AV

Mol Med · 2025 · 31(1):303

Dual inhibition of MAPK and TORC1 signaling retards development of radiation resistance in pediatric BRAFV600E glioma models

Li F, Bondra KM, Wang H, Kurmashev D, Mukherjee B, Kanji S, Habib AA, Chen Y, Zheng S, Burma S, Houghton PJ

Neuro Oncol · 2025 · 27(7):1787-1800

Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory

Timilsina S, Huang JY, Abdelfattah N, Medina D, Singh D, Abdulsahib S … Bhandari M, Zheng S, Chen Y … Rao MK

Nat Commun · 2025 · 16(1):3967

Benchmarking mouse contamination removing protocols in patient-derived xenografts genomic profiling

Bhandari M, He F, Rogojina A, Li F, Zou Y, Jiang J, Lai Z, Houghton P, Kurmasheva RT, Chen Y, Wang X, Zheng S

NPJ Precis Oncol · 2025 · 9(1):113 First / senior author

2024

Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients

Das D, Wang X, Chiu YC, Bouamar H, Sharkey FE, Lopera JE … Chen Y, Zheng S*, Cigarroa FG*, Sun LZ*

J Natl Cancer Inst · 2024 · 116(12):1961-1978 First / senior author

Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset

Xu Y, Nipper MH, Dominguez AA, Ye Z, Akanuma N, Lopez K … Sun LZ, Zheng S, Chen Y … Wang P

Nat Commun · 2024 · 15(1):818

2023

Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer

He F, Bandyopadhyay AM, Klesse LJ, Rogojina A, Chun SH, Butler E … Kurmasheva RT, Zheng S

Nat Commun · 2023 · 14(1):7600 First / senior author

Comprehensive characterization of patient-derived xenograft models of pediatric leukemia

Rogojina A, Klesse LJ, Butler E, Kim J, Zhang H, Xiao X … Gidvani-Diaz V, Zheng S, Lai Z … Xu L

iScience · 2023 · 26(11):108171

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

Alejo S, Palacios BE, Venkata PP, He Y, Li W, Johnson JD … Zhao W, Zheng S, Vadlamudi RK … Sareddy GR

Neuro Oncol · 2023 · 25(7):1249-1261

DepLink: an R Shiny app to systematically link genetic and pharmacologic dependencies of cancer

Nayak T, Wang LJ, Ning M, Rubannelsonkumar G, Jin E, Zheng S, Houghton PJ, Huang Y, Chiu YC, Chen Y

Bioinform Adv · 2023 · 3(1):vbad076

OpenPBTA: The Open Pediatric Brain Tumor Atlas

Shapiro JA, Gaonkar KS, Spielman SJ, Savonen CL, Bethell CJ, Jin R … Diskin SJ, Zheng S, Guo Y … Pacific Pediatric Neuro-Oncology Consortium

Cell Genom · 2023 · 3(7):100340

Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages

Wu M, Wu L, Wu W, Zhu M, Li J, Wang Z … Wang X, Zheng S, Chen J … Wang Q

Cancer Res · 2023 · 83(5):771-785

2022

Protocol to benchmark gene expression signature scoring techniques for single-cell RNA sequencing data in cancer

Noureen N, Wang X, Zheng S

STAR Protoc · 2022 · 3(4):101877 First / senior author

Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma

Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M … Hu B, Zheng S, Hu Z … Wang Q

Cancer Discov · 2022 · 12(12):2820-2837

Genomic disparities between cancers in adolescent and young adults and in older adults

Wang X, Langevin AM, Houghton PJ, Zheng S

Nat Commun · 2022 · 13(1):7223 First / senior author

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth

Blankenship L, Pratap UP, Yang X, Liu Z, Altwegg KA, Santhamma B … Lai Z, Zheng S, Sareddy GR … Viswanadhapalli S

Cancers (Basel) · 2022 · 14(21)

M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression

Yadav P, Subbarayalu P, Medina D, Nirzhor S, Timilsina S, Rajamanickam S … Gupta Y, Zheng S, Abdelfattah N … Rao MK

Cancer Res · 2022 · 82(10):1872-1889

Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data

Noureen N, Ye Z, Chen Y, Wang X, Zheng S

Elife · 2022 · 11 First / senior author

Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma

Ghilu S, Morton CL, Vaseva AV, Zheng S, Kurmasheva RT, Houghton PJ

Cancer Drug Resist · 2022 · 5(1):80-89

2021

SNAI2-Mediated Repression of BIM Protects Rhabdomyosarcoma from Ionizing Radiation

Wang L, Hensch NR, Bondra K, Sreenivas P, Zhao XR, Chen J … Stanton BZ, Zheng S, Chen EY … Ignatius MS

Cancer Res · 2021 · 81(21):5451-5463

Predicting and characterizing a cancer dependency map of tumors with deep learning

Chiu YC, Zheng S, Wang LJ, Iskra BS, Rao MK, Houghton PJ, Huang Y, Chen Y

Sci Adv · 2021 · 7(34)

Regulation of telomere homeostasis and genomic stability in cancer by N (6)-adenosine methylation (m(6)A)

Lee JH, Hong J, Zhang Z, de la Peña Avalos B, Proietti CJ, Deamicis AR … Rao MK, Zheng S, Johnson-Pais TL … Xu K

Sci Adv · 2021 · 7(31)

A modular master regulator landscape controls cancer transcriptional identity

Paull EO, Aytes A, Jones SJ, Subramaniam PS, Giorgi FM, Douglass EF … Vasciaveo A, Zheng S, Verhaak R … Califano A

Cell · 2021 · 184(2):334-351.e20

PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models

Yang J, Li Q, Noureen N, Fang Y, Kurmasheva R, Houghton PJ, Wang X, Zheng S

Nucleic Acids Res · 2021 · 49(D1):D1321-D1327 First / senior author

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation

Noureen N, Wu S, Lv Y, Yang J, Alfred Yung WK, Gelfond J, Wang X, Koul D, Ludlow A, Zheng S

Nat Commun · 2021 · 12(1):139 First / senior author

2020

Deep learning of pharmacogenomics resources: moving towards precision oncology

Chiu YC, Chen HH, Gorthi A, Mostavi M, Zheng S, Huang Y, Chen Y

Brief Bioinform · 2020 · 21(6):2066-2083

Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution

Li Y, Li B, Li W, Wang Y, Akgül S, Treisman DM … Rehemtulla A, Zheng S, Ross BD … Zhu Y

Nat Commun · 2020 · 11(1):3669

Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway

VanCleave A, Palmer M, Fang F, Torres H, Rodezno T, Li Q … Leiferman P, Zheng S, Houghton P, Tao J

Oncotarget · 2020 · 11(27):2597-2610

MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome

Qiu Z, Lin AP, Jiang S, Elkashef SM, Myers J, Srikantan S … Lyu Y, Zheng S, Madesh M … Aguiar RCT

Cell Chem Biol · 2020 · 27(5):538-550.e7

EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma

Wu S, Gao F, Zheng S, Zhang C, Martinez-Ledesma E, Ezhilarasan R … Koul D

Clin Cancer Res · 2020 · 26(6):1395-1407

Prospective use of the single-mouse experimental design for the evaluation of PLX038A

Ghilu S, Li Q, Fontaine SD, Santi DV, Kurmasheva RT, Zheng S, Houghton PJ

Cancer Chemother Pharmacol · 2020 · 85(2):251-263

2019

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Rokita JL, Rathi KS, Cardenas MF, Upton KA, Jayaseelan J, Cross KL … Kurmashev D, Zheng S, Chen Y … Maris JM

Cell Rep · 2019 · 29(6):1675-1689.e9

Tie2-FGFR1 Interaction Induces Adaptive PI3K Inhibitor Resistance by Upregulating Aurora A/PLK1/CDK1 Signaling in Glioblastoma

Li X, Martinez-Ledesma E, Zhang C, Gao F, Zheng S, Ding J … Koul D

Cancer Res · 2019 · 79(19):5088-5101

Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau Disease

Flores SK, Cheng Z, Jasper AM, Natori K, Okamoto T, Tanabe A … Young W, Zheng S, Takekoshi K … Dahia PLM

J Clin Endocrinol Metab · 2019 · 104(9):3826-3834

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling

Sareddy GR, Pratap UP, Viswanadhapalli S, Venkata PP, Nair BC, Krishnan SR, Zheng S, Gilbert AR, Brenner AJ, Brann DW, Vadlamudi RK

Neurooncol Adv · 2019 · 1(1):vdz042

Prospective Clinical Sequencing of Adult Glioma

Zheng S, Alfaro-Munoz K, Wei W, Wang X, Wang F, Eterovic AK … de Groot JF

Mol Cancer Ther · 2019 · 18(5):991-1000 First / senior author

2018

Profiles of brain metastases: Prioritization of therapeutic targets

Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK … Heimberger AB

Int J Cancer · 2018 · 143(11):3019-3026

Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma

Akgül S, Li Y, Zheng S, Kool M, Treisman DM, Li C … Zhu Y

Cell Rep · 2018 · 24(2):463-478.e5

Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

deCarvalho AC, Kim H, Poisson LM, Winn ME, Mueller C, Cherba D … Felicella M, Zheng S, Multani A … Verhaak RGW

Nat Genet · 2018 · 50(5):708-717

Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma

Wu S, Wang S, Gao F, Li L, Zheng S, Yung WKA, Koul D

Neuro Oncol · 2018 · 20(1):78-91

TumorFusions: an integrative resource for cancer-associated transcript fusions

Hu X, Wang Q, Tang M, Barthel F, Amin S, Yoshihara K, Lang FM, Martinez-Ledesma E, Lee SH, Zheng S*, Verhaak RGW*

Nucleic Acids Res · 2018 · 46(D1):D1144-D1149 First / senior author

2017

ARID1B alterations identify aggressive tumors in neuroblastoma

Lee SH, Kim JS, Zheng S, Huse JT, Bae JS, Lee JW, Yoo KH, Koo HH, Kyung S, Park WY, Sung KW

Oncotarget · 2017 · 8(28):45943-45950

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L … Martinez-Ledesma E, Zheng S, Chang E … Verhaak RGW

Cancer Cell · 2017 · 32(1):42-56.e6

Benchmarking: contexts and details matter

Zheng S

Genome Biol · 2017 · 18(1):129 First / senior author

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, Cancer Genome Atlas Research Network

Cell · 2017 · 169(7):1327-1341.e23

Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma

Hu X, Martinez-Ledesma E, Zheng S, Kim H, Barthel F, Jiang T, Hess KR, Verhaak RGW

Neuro Oncol · 2017 · 19(6):786-795

APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death

Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Alfred Yung WK

Oncotarget · 2017 · 8(33):54285-54296

Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma

Koul D, Wang S, Wu S, Saito N, Zheng S, Gao F … Yung WKA

Oncotarget · 2017 · 8(13):21741-21753

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG … Kwong LN

Cell Rep · 2017 · 18(11):2780-2794

Systematic analysis of telomere length and somatic alterations in 31 cancer types

Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X, Amin SB … Zhang J, Zheng S*, Verhaak RG*

Nat Genet · 2017 · 49(3):349-357 First / senior author

Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation

Shingu T, Ho AL, Yuan L, Zhou X, Dai C, Zheng S, Wang Q … Hu J

Nat Genet · 2017 · 49(1):75-86

2016

MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma

Wu S, Wang S, Zheng S, Verhaak R, Koul D, Yung WK

Mol Cancer Ther · 2016 · 15(7):1656-68

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA … Verhaak RGW

Cancer Cell · 2016 · 29(5):723-736 First / senior author

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA … Barnholtz-Sloan JS, Zheng S, Hess K … Verhaak RG

Cell · 2016 · 164(3):550-63

2015

Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma

Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG … Hofmann MC, Zheng S, Verhaak R … Habra MA

Cancer Res · 2015 · 75(19):4131-42

The landscape and therapeutic relevance of cancer-associated transcript fusions

Yoshihara K, Wang Q, Torres-Garcia W, Zheng S, Vegesna R, Kim H, Verhaak RG

Oncogene · 2015 · 34(37):4845-54

Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain

Geisenberger C, Mock A, Warta R, Rapp C, Schwager C, Korshunov A … Lahrmann B, Zheng S, Verhaak RG … Herold-Mende C

Acta Neuropathol · 2015 · 130(3):419-34

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR … Yoshihara K, Zheng S, Zhang W … Zhang J

N Engl J Med · 2015 · 372(26):2481-98

Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution

Kim H*, Zheng S*, Amini SS, Virk SM, Mikkelsen T, Brat DJ … Verhaak RG

Genome Res · 2015 · 25(3):316-27 First / senior author

Advances in computational genomics

Han L, Guo Y, Su Z, Zheng S, Lu Z

Biomed Res Int · 2015 · 2015:187803

2014

Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S … Stuart JM

Cell · 2014 · 158(4):929-944

PRADA: pipeline for RNA sequencing data analysis

Torres-García W*, Zheng S*, Sivachenko A, Vegesna R, Wang Q, Yao R, Berger MF, Weinstein JN, Getz G, Verhaak RG

Bioinformatics · 2014 · 30(15):2224-6 First / senior author

The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes

Han L, Yuan Y, Zheng S, Yang Y, Li J, Edgerton ME, Diao L, Xu Y, Verhaak RGW, Liang H

Nat Commun · 2014 · 5:3963

Silent mutations make some noise

Zheng S, Kim H, Verhaak RGW

Cell · 2014 · 156(6):1129-1131 First / senior author

Molecular subtypes of glioblastoma are relevant to lower grade glioma

Guan X*, Vengoechea J*, Zheng S*, Sloan AE, Chen Y, Brat DJ … Barnholtz-Sloan JS

PLoS One · 2014 · 9(3):e91216 First / senior author

ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state

Chudnovsky Y, Kim D, Zheng S, Whyte WA, Bansal M, Bray MA … Chheda MG

Cell Rep · 2014 · 6(2):313-24

A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells

Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD … Koul D

Stem Cells · 2014 · 32(1):301-12

2013

Intragenic breakpoint: a marker of genome instability in glioblastoma

Zheng S, Verhaak RG

Cell Cycle · 2013 · 12(24):3705-6 First / senior author

The somatic genomic landscape of glioblastoma

Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D … TCGA Research Network

Cell · 2013 · 155(2):462-77

The Cancer Genome Atlas Pan-Cancer analysis project

Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM

Nat Genet · 2013 · 45(10):1113-20

A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival

Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W … Verhaak RG

Genes Dev · 2013 · 27(13):1462-72 First / senior author

Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction

Hill MF, Patel AV, Murphy A, Smith HM, Galindo CL, Pentassuglia L … Kronenberg MW, Zheng S, Zhao Z … Sawyer DB

PLoS One · 2013 · 8(2):e55741

2012

Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance

Flynn C, Zheng S, Yan L, Hedges L, Womack B, Fessel J, Cogan J, Austin E, Loyd J, West J, Zhao Z, Hamid R

Am J Respir Cell Mol Biol · 2012 · 47(1):20-7

DNA methylation profiling distinguishes three clusters of breast cancer cell lines

Zheng S, Zhao Z

Chem Biodivers · 2012 · 9(5):848-56 First / senior author

GenRev: exploring functional relevance of genes in molecular networks

Zheng S, Zhao Z

Genomics · 2012 · 99(3):183-8 First / senior author

Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells

Sun Y*, Zheng S*, Torossian A, Speirs CK, Schleicher S, Giacalone NJ, Carbone DP, Zhao Z, Lu B

Int J Radiat Oncol Biol Phys · 2012 · 82(3):e563-72 First / senior author

Studying a complex tumor: potential and pitfalls

Zheng S, Chheda MG, Verhaak RG

Cancer J · 2012 · 18(1):107-14 First / senior author

2011

Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma

Zheng S, Tansey WP, Hiebert SW, Zhao Z

BMC Med Genomics · 2011 · 4:62 First / senior author

Association of feature gene expression with structural fingerprints of chemical compounds

Li Y, Tu K, Zheng S, Wang J, Li Y, Hao P, Li X

J Bioinform Comput Biol · 2011 · 9(4):503-19

Epithelial cell organization suppresses Myc function by attenuating Myc expression

Simpson DR, Yu M, Zheng S, Zhao Z, Muthuswamy SK, Tansey WP

Cancer Res · 2011 · 71(11):3822-30

dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks

Jia P*, Zheng S*, Long J, Zheng W, Zhao Z

Bioinformatics · 2011 · 27(1):95-102 First / senior author

2010

Hdac3 is essential for the maintenance of chromatin structure and genome stability

Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S, Yenamandra A … Hiebert SW

Cancer Cell · 2010 · 18(5):436-47

A comparative analysis of liver transcriptome suggests divergent liver function among human, mouse and rat

Yu Y, Ping J, Chen H, Jiao L, Zheng S, Han ZG, Hao P, Huang J

Genomics · 2010 · 96(5):281-9

Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer

Chen G, Yang N, Wang X, Zheng SY, Chen Y, Tong LJ, Li YX, Meng LH, Ding J

J Mol Med (Berl) · 2010 · 88(9):941-52

PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach

Liu X, Ouyang S, Yu B, Liu Y, Huang K, Gong J, Zheng S, Li Z, Li H, Jiang H

Nucleic Acids Res · 2010 · 38(Web Server issue):W609-14

Discovering disease-specific biomarker genes for cancer diagnosis and prognosis

Huang HC, Zheng S, VanBuren V, Zhao Z

Technol Cancer Res Treat · 2010 · 9(3):219-30

2009

GEOGLE: context mining tool for the correlation between gene expression and the phenotypic distinction

Yu Y, Tu K, Zheng S, Li Y, Ding G, Ping J, Hao P, Li Y

BMC Bioinformatics · 2009 · 10:264

Human gene expression sensitivity according to large scale meta-analysis

Hao P*, Zheng S*, Ping J, Tu K, Gieger C, Wang-Sattler R, Zhong Y, Li Y

BMC Bioinformatics · 2009 · 10 Suppl 1(Suppl 1):S56 First / senior author

2008

Ab-origin: an enhanced tool to identify the sourcing gene segments in germline for rearranged antibodies

Wang X, Wu D, Zheng S, Sun J, Tao L, Li Y, Cao Z

BMC Bioinformatics · 2008 · 9 Suppl 12(Suppl 12):S20

Gene expression module-based chemical function similarity search

Li Y, Hao P, Zheng S, Tu K, Fan H, Zhu R … Li Y

Nucleic Acids Res · 2008 · 36(20):e137

MPSQ: a web tool for protein-state searching

Zheng S, Sheng J, Wang C, Wang X, Yu Y, Li Y, Michie A, Dai J, Zhong Y, Hao P, Liu L, Li Y

Bioinformatics · 2008 · 24(20):2412-3 First / senior author

2006

Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene

Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, Liu J, Zhao Y, Chen J, Ning G, Li X

J Clin Endocrinol Metab · 2006 · 91(9):3619-25

No publications match this filter.